Amneal Pharmaceuticals: A Large, Diversified Clinical Portfolio That Keeps Growing (AMRX)

Amneal is a pharma brand with a diverse and growing drug portfolio, strong cash flow metrics, and an improving debt situation. Read why I rate AMRX stock a buy.